Bradley Foster & Sargent’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $538K | Hold |
6,250
| – | – | 0.01% | 398 |
|
|
2026
Q1 | $565K | Sell |
6,250
-16
| -0.3% | -$1.47K | 0.01% | 376 |
|
|
2025
Q4 | $563K | Sell |
6,266
-16
| -0.3% | -$1.52K | 0.01% | 377 |
|
|
2025
Q3 | $619K | Sell |
6,282
-15
| -0.2% | -$1.49K | 0.01% | 368 |
|
|
2025
Q2 | $574K | Buy |
6,297
+69
| +1% | +$6.67K | 0.01% | 368 |
|
|
2025
Q1 | $705K | Hold |
6,228
| – | – | 0.01% | 307 |
|
|
2024
Q4 | $658K | Hold |
6,228
| – | – | 0.01% | 327 |
|
|
2024
Q3 | $672K | Sell |
6,228
-207
| -3% | -$22.6K | 0.01% | 330 |
|
|
2024
Q2 | $698K | Sell |
6,435
-24
| -0.4% | -$2.83K | 0.01% | 318 |
|
|
2024
Q1 | $852K | Buy |
6,459
+7
| +0.1% | +$874 | 0.02% | 290 |
|
|
2023
Q4 | $785K | Hold |
6,452
| – | – | 0.02% | 298 |
|
|
2023
Q3 | $939K | Hold |
6,452
| – | – | 0.02% | 269 |
|
|
2023
Q2 | $939K | Hold |
6,452
| – | – | 0.02% | 269 |
|
|
2023
Q1 | $834K | Hold |
6,452
| – | – | 0.02% | 268 |
|
|
2022
Q4 | $823K | Buy |
6,452
+85
| +1% | +$9.86K | 0.02% | 269 |
|
|
2022
Q3 | $666K | Hold |
6,367
| – | – | 0.02% | 281 |
|
|
2022
Q2 | $669K | Buy |
6,367
+1,000
| +19% | +$119K | 0.02% | 280 |
|
|
2022
Q1 | $686K | Buy |
5,367
+54
| +1% | +$6.51K | 0.01% | 309 |
|
|
2021
Q4 | $655K | Sell |
5,313
-165
| -3% | -$21.6K | 0.01% | 298 |
|
|
2021
Q3 | $778K | Buy |
5,478
+3
| +0.1% | +$441 | 0.02% | 260 |
|
|
2021
Q2 | $855K | Hold |
5,475
| – | – | 0.02% | 252 |
|
|
2021
Q1 | $851K | Sell |
5,475
-82
| -1% | -$12.7K | 0.02% | 244 |
|
|
2020
Q4 | $831K | Sell |
5,557
-115
| -2% | -$16.2K | 0.02% | 236 |
|
|
2020
Q3 | $750K | Buy |
+5,672
| New | +$741K | 0.02% | 225 |
|
|
2020
Q1 | $557K | Hold |
5,671
| – | – | 0.02% | 225 |
|
|
2019
Q4 | $824K | Hold |
5,671
| – | – | 0.03% | 231 |
|
|
2019
Q3 | $756K | Buy |
5,671
+516
| +10% | +$66.7K | 0.03% | 229 |
|
|
2019
Q2 | $589K | Sell |
5,155
-1,258
| -20% | -$147K | 0.02% | 249 |
|
|
2019
Q1 | $795K | Sell |
6,413
-589
| -8% | -$66.9K | 0.03% | 225 |
|
|
2018
Q4 | $705K | Buy |
7,002
+26
| +0.4% | +$2.92K | 0.03% | 229 |
|
|
2018
Q3 | $891K | Hold |
6,976
| – | – | 0.03% | 233 |
|
|
2018
Q2 | $755K | Buy |
6,976
+435
| +7% | +$47.3K | 0.03% | 242 |
|
|
2018
Q1 | $692K | Hold |
6,541
| – | – | 0.03% | 244 |
|
|
2017
Q4 | $766K | Sell |
6,541
-5,657
| -46% | -$640K | 0.03% | 237 |
|
|
2017
Q3 | $1.39M | Sell |
12,198
-6,670
| -35% | -$770K | 0.05% | 188 |
|
|
2017
Q2 | $2.35M | Buy |
18,868
+3,302
| +21% | +$391K | 0.09% | 148 |
|
|
2017
Q1 | $1.84M | Buy |
15,566
+9,355
| +151% | +$1.06M | 0.07% | 160 |
|
|
2016
Q4 | $622K | Hold |
6,211
| – | – | 0.03% | 243 |
|
|
2016
Q3 | $784K | Sell |
6,211
-58
| -0.9% | -$7.17K | 0.03% | 216 |
|
|
2016
Q2 | $733K | Sell |
6,269
-6
| -0.1% | -$679 | 0.03% | 215 |
|
|
2016
Q1 | $650K | Sell |
6,275
-148
| -2% | -$14.3K | 0.03% | 228 |
|
|
2015
Q4 | $640K | Sell |
6,423
-180
| -3% | -$17.6K | 0.03% | 219 |
|
|
2015
Q3 | $602K | Sell |
6,603
-2,464
| -27% | -$247K | 0.03% | 224 |
|
|
2015
Q2 | $962K | Buy |
9,067
+937
| +12% | +$104K | 0.04% | 199 |
|
|
2015
Q1 | $928K | Sell |
8,130
-257
| -3% | -$29.3K | 0.04% | 204 |
|
|
2014
Q4 | $924K | Sell |
8,387
-141
| -2% | -$14.9K | 0.04% | 195 |
|
|
2014
Q3 | $833K | Buy |
8,528
+103
| +1% | +$10.1K | 0.04% | 209 |
|
|
2014
Q2 | $850K | Buy |
8,425
+3,708
| +79% | +$362K | 0.04% | 205 |
|
|
2014
Q1 | $433K | Hold |
4,717
| – | – | 0.02% | 257 |
|
|
2013
Q4 | $427K | Buy |
+4,717
| New | +$408K | 0.02% | 262 |
|
Other funds holding ZBH
Bradley Foster & Sargent's ZBH Position: Q2 2026 in Review
Bradley Foster & Sargent held its Zimmer Biomet (ZBH) position steady in Q2 2026 at 6,250 shares worth $538K. The position accounts for 0.01% of the portfolio, ranked #398.
Bradley Foster & Sargent first reported a position in ZBH in Q4 2013 and has held it in 50 quarters since. The position peaked at $2.35M in Q2 2017. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.
- Bradley Foster & Sargent held 6,250 shares of Zimmer Biomet worth $538K as of Q2 2026.
- Bradley Foster & Sargent left its Zimmer Biomet share count unchanged in Q2 2026.
- Zimmer Biomet made up 0.01% of Bradley Foster & Sargent's portfolio in Q2 2026, its #398 holding.
- Bradley Foster & Sargent first reported a position in Zimmer Biomet in Q4 2013 and has held it in 50 quarters since.
- Bradley Foster & Sargent's Zimmer Biomet position peaked at $2.35M in Q2 2017.
- 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.
Based on Bradley Foster & Sargent's 13F filing for Q2 2026, filed 14 Aug 2026.